Atlas Trials

Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities.

Clinical trial NCT05375097 · COMPLETED

Trial details

NCT number
NCT05375097
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Migraine
Start date
2020-07-03
Primary completion
2021-05-14
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.